At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 6,000 target
Drug / intervention
Observational Studyother
Likely dose
Not stated in record
Key inclusion· 3
- ✓Hospitalized patients with positive SARS-CoV-2 biological samples
- ✓Hospitalized patients with negative test but clinical and radiological features highly suggestive of SARS-CoV-2 disease
- ✓Discharged from emergency department with positive SARS-CoV-2 biological samples
Key exclusion· 0
None specified.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response
In Brief
An observational study evaluating Observational Study for Coronavirus Infections. Currently recruiting, targeting 6,000 participants across 13 sites.
Detailed Summary
Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronavirus Infections
CountriesItaly
Collaborators--
Timeline
N/ARecruitingOverdue
202120222023202420252026
Enrollment StartMar 2020
First PostedMar 2020
Primary CompletionJun 2026
TodayJul 2026
First PostedMar 24, 2020
Enrollment StartMar 19, 2020
Primary CompletionJun 19, 2026
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 6.3 years ago
Interventions
Observational Studyother
Not required